BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4855503)

  • 1. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR
    N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 6. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH; Pryor ND; Fennell RS; Richard GA
    J Pediatr; 1978 Feb; 92(2):304-8. PubMed ID: 621614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of chlorambucil in the nephrotic syndrome (NS) with frequent recurrences in children].
    Ciardi MR; Ginevri F; Perfumo F; Gusmano R
    Minerva Nefrol; 1979; 26(4):495-600. PubMed ID: 542219
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C; Broyer M; Jarde O; Guillot M
    Paediatrician; 1981; 10(5-6):382-99. PubMed ID: 7036046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
    Chiu J; McLaine PN; Drummond KN
    J Pediatr; 1973 Apr; 82(4):607-13. PubMed ID: 4698337
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide.
    Sa GA; Luis JP; Mendonca E; Almeida M; Rosa FC
    Pediatr Nephrol; 1996 Apr; 10(2):250. PubMed ID: 8703725
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP; Stapleton FB; Roy S; Wyatt RJ
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie
    N Engl J Med; 1982 Feb; 306(8):451-4. PubMed ID: 7035953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with cytotoxic drugs in therapy of the nephrotic syndrome].
    Brandis M; Krohn HP; Hanke K; Brodehl J
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):566-8. PubMed ID: 876240
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlorambucil in steroid-dependent nephrotic syndrome.
    Grupe WE
    J Pediatr; 1973 Apr; 82(4):598-606. PubMed ID: 4121460
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.